Table 1.
ACC patient biochemistry
| Hormone | March 2014 preoperative | April 2014 postoperative | April 2015 | February 2016 | June 2017 | November 2017 | May 2018 |
|---|---|---|---|---|---|---|---|
| Cortisol (150–520 nmol/L) | 748 | 33 | 464 | 445 | 309 | 397 | |
| ACTH (0–12 pmol/L) | <2.2 | 24.9 | 14.0 | 13.7 | 17.5 | ||
| Midnight salivary cortisol (0–10 nmol/L) | 19 | ||||||
| 24 UFC (0–250 nmol/d) | 414 | ||||||
| 1 mg overnight DST | 680 | ||||||
| Low-dose DST | 505 | ||||||
| DHEAS (premenopausal 2.2–9.1 µmol/L) | 6.9 | <0.9 | <0.9 | <0.9 | 0.4 | <0.4 | <0.4 |
| Androstenedione (premenopausal 2.5–10 nmol/L) | 30 | 0.3 | 1.6 | 1.6 | 1.6 | 2.1 | 2.6 |
| Testosterone (0–1.8 nmol/L) | 4.9 | <0.3 | <0.3 | <0.3 | <0.3 | <0.3 | <0.3 |
| Free testosterone (0–24 pmol/L) | 71 | <6 | |||||
| SHBG (20–110 nmol/L) | 61 | ||||||
| 17 OH Progesterone (1.2–17 nmol/L luteal phase) | 55.9 | ||||||
| Plasma catecholamines | Normal | ||||||
| Urine catecholamines | Normal | ||||||
| Aldosterone/renin ratio | 0.5 |
Bold type indicates numbers that exceed the normal range provided in the first column. (ACTH) Adrenocorticotropic hormone, (DHEAS) dehydroepiandrosterone, (DST) dexamethasone suppression test, (SHBG) sex hormone-binding globulin, (UFC) urine-free cortisol.